长春新碱治疗糖尿病肾病大鼠的实验研究

目的验证长春新碱对糖尿病肾病大鼠的治疗作用。方法用链脲佐菌素(STZ)诱导大鼠糖尿病模型。将模型大鼠分为治疗组与非治疗组,治疗组给予长春新碱(VCR)0.2 mg/kg,尾静脉注射,每周2次,观察给药后大鼠血糖、尿蛋白、肾功能、肾重,体重等值的改变以及肾脏病理的改善情况。结果 治疗组大鼠尿蛋白明显减少,肾重/体重低于非治疗组。光镜下观察治疗组肾脏病理学变化情况有明显改善。结论长春新碱可降低糖尿病肾病大鼠的尿蛋白并改善糖尿病肾病早期病理损害。     

The influence of Glu44 and Glu56 of cytochrome b5 on the protein structure and interaction with cytochrome c

The gene encoding trypsin-solubilized bovine liver microsomalcytochrome b₅ (82 residues in length) has been mutated, in whichthe codons of Glu44 and Glu56 were changed to those of Ala.The mutated genes were expressed in Escherichia coli successfullyand three mutant proteins (E44A, E56A and E44/56A) were obtained.The UV-visible, CD and ¹H NMR spectra of proteins have beenstudied. The results show that the mutagenesis at surface residuesdoes not alter the secondary and tertiary structures of cytochromeb₅ significantly. The interactions between recombinant cytochromeb₅ and its mutants with cytochrome c were studied by using opticaldifference spectra. The results demonstrated that both Glu44and Glu56 of cytochrome b₅ participate in the formation of acomplex between cytochrome b₅ and cytochrome c.     

妊娠相关血浆蛋白A的分离及纯化

采用人胎盘血为原料,利用Sephadex G-200,DEAE-Sephadex A-50层析,Sepharose 4B反相免疫亲和层析技术,获得妊娠相关血浆蛋白A(PAPP-A)纯品,经8.0％聚丙烯酰胺凝胶电泳、免疫电泳、双向免疫扩散证明,所提取的PAPP-A纯品为单一成分。免疫家兔获得抗血清,其效价在1:16以上。     

Chromatographic performance of monodisperse–macroporous particles produced by “modified seeded polymerization.” I: Effect of monomer/seed latex ratio

In this study, the monodisperse–macroporous particles produced by a relatively new polymerization protocol, the so‐called, “modified seeded polymerization,” were used as column‐packing material in the reversed phase chromatography (RPC) of proteins. The particles were synthesized in the form of styrene‐divinylbenzene copolymer approximately 7.5 μm in size. In the first stage of the synthesis, the monodisperse polystyrene particles 4.4 μm in size were obtained by dispersion polymerization and used as the “seed latex.” The seed particles were swollen by a low‐molecular‐weight organic agent and then by a monomer mixture. The monodisperse–macroporous particles were obtained by the polymerization of monomer mixture in the seed particles. In the proposed polymerization protocol, the number of successive swelling stages was reduced with respect to the present techniques by the use of sufficiently large particles with an appropriate average molecular weight as the seed latex. A series of particles with different porosity properties was obtained by varying the monomer/seed latex ratio. The separation behavior of HPLC columns including the produced particles as packing material was investigated in the RPC mode using a protein mixture including albumin, lysozyme, cytochrome c, and ribonuclease A. The chromatograms were obtained with different flow rates under an acetonitrile–water gradient. The theoretical plate number increased and chromatograms with higher resolutions were obtained with the particles produced by using a lower monomer/seed latex ratio. The separation ability of the column could be protected over a wide range of flow rates (i.e., 0.5–3 mL/min) with most of the materials tested. © 2004 Wiley Periodicals, Inc. J Appl Polym Sci 92: 607–618, 2004     

重组B7-H1IgV融合蛋白的表达、纯化及活性鉴定

目的以B7-H1为靶点,研制肿瘤免疫治疗蛋白疫苗。方法将人B7-H1胞外片段IgV区基因插入pQE-30原核表达载体,转化大肠杆菌,经IPTG诱导表达。Ni2+-NTA亲和层析纯化蛋白,Westernblot鉴定。用纯化的rhB7-H1IgV蛋白免疫昆明小鼠,经ELISA、流式细胞术、免疫组化技术和CDC试验测定融合蛋白及其抗血清的生物学活性。结果所构建的pQE-30-TT-B7-H1IgV表达载体,能稳定表达rhB7-H1IgV蛋白,经纯化后免疫昆明小鼠,可获得高滴度抗B7-H1抗血清。经流式细胞术和免疫组化检测显示,其抗血清可与HT-29/B7-H1+及SP2/0肿瘤细胞结合,且在CDC试验中,可依赖补体杀伤HT-29/B7-H1+及SP2/0肿瘤细胞。结论rhB7-H1IgV融合蛋白不仅可引发小鼠体液免疫应答,而且其抗体还能与表达B7-H1的肿瘤细胞相结合,并介导补体依赖的体外杀伤作用。     

Polarity as a criterion in protein design

Hypothetical proteins can be tested computationally by determiningwhether or not the designed sequence-structure pair has thecharacteristics of a typical globular protein. We have developedsuch a test by deriving quantities with approximately constantvalue for all globular proteins, based on empirical analysisof the exposed and buried surfaces of 128 structurally knownproteins. The characteristic quantities that best appear tosegregate badly designed or deliberately misfolded proteinsfrom their properly folded natural relatives are the polar fractionof side chains on the protein surface and, independently, inthe protein interior. Three of the seven hypothetical structurestested here can be rejected as having too many polar side-chaingroups in the interior or too few on the protein surface. Inaddition, a recently designed nutritional protein is identifiedas being very much unlike globular proteins. These database-derivedcharacteristic quantities are useful in screening designed proteinsprior to experiment and may be useful in screening experimentallydetermined (X-ray, NMR) protein structures for possible errors.     

An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure

A 3-D model of a protein can be constructed from its amino acidsequence and the 3-D structures of one or more homologues byannealing three sets of fragments: the structurally conservedregions, structurally variable regions and the side chains.The method encoded in the computer program COMPOSER was assessedby generating 3-D models of eight proteins whose crystal structuresare already known and for which 3-D structures of homologuesare available. In the structurally conserved regions, differencesbetween modelled and X-ray structures are smaller than the differencesbetween the X-ray structures of the modelled protein and thehomologues used to build the model. When several homologuesare used, the contributions of the known structures are weighted,preferably by the square of sequence similarity; this is especiallyimportant when the similarities of the homologues to the modelledstructure differ greatly. The ‘collar’ extensionapproach, in which a similar region of different length in ahomologue is used to extend the framework, can result in a moreaccurate model. If known homologues comprise more than one relatedgroup of proteins and they are both distantly related to theunknown, then alignment of the sequence to be modelled witheach group of homologues facilitates identification of structurallyconserved regions of the unknown and leads to an improved model.Models have root mean square differences (r.m.s.d.s) with thestructures defined by X-ray analysis of between 0.73 and 1.56Å for all C atoms, for seven of the eight models. Forthe model of mucor pepsin, where the closest homologue has 33%sequence identity and 20% of the residues are in structurallyvariable regions, the r.m.s.d. for the framework region is 1.71Å and the r.m.s.d. for all C atoms is 3.47 Â.     

蛋白质在超滤过程中的膜污染和膜清洗

本文选用四种不同的膜清洗剂对牛血清蛋白溶液超滤后污染的三种超滤膜进行研究，结果表明：在蛋白质的等电点取得在不同ＰＨ值下蛋白质对膜污染的最佳清洗效果，清洗效率与蛋白质的所荷电荷有关。采用适宜的清洗过程将会延长膜使用寿命和增强超滤膜性能。     

Vero细胞蛋白过敏原性研究

目的　研究Vero细胞蛋白的过敏原性。方法　取不同剂量Vero细胞宿主细胞蛋白和裂解蛋白致敏豚鼠 ,隔日 1次 ,共 3次 ,每组 3只 ,以牛血清及生理盐水分别为阳性及阴性对照 ,末次致敏后 2 1d攻击 ,并观察攻击后的反应。结果　攻击后 30min ,10 0ng 只以上剂量组均出现过敏反应 ,且反应强度与剂量呈正相关。 2 4h各剂量组过敏反应的恢复情况各不相同。结论　Vero细胞宿主细胞蛋白及裂解蛋白均可以引起过敏反应 ,裂解蛋白的反应强度高于宿主细胞蛋白。     

重组人白细胞介素-10在大肠杆菌中的表达及生物学活性分析

目的在大肠杆菌中表达重组人白细胞介素-10(Interleukin-10,IL-10),并检测其生物学活性。方法将IL-10基因重组到质粒pET11c中,转化BL21(DE),提取质粒,经酶切鉴定和测序分析;在25℃用低浓度的IPTG诱导表达,对包涵体IL-10稀释复性;经ELISA检测其含量,MC/9细胞增殖法检测其生物学活性。结果工程菌IL-10/pET11c/BL21诱导表达的目的蛋白以可溶性和包涵体两种形式存在,Westernblot鉴定证实为IL-10蛋白,两种形式的IL-10均具有一定的生物学活性。结论已成功地在大肠杆菌中表达了IL-10,为进一步纯化和制备IL-10的基因工程药物打下了基础。